BA
TGTX icon

BlackRock Advisors’s TG Therapeutics TGTX Stock Holding History

BlackRock Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$88K Sell
18,942
-738
-4% -$4.33K ﹤0.01% 3086
2016
Q3 		$152K Buy
19,680
+1,549
+9% +$9.96K ﹤0.01% 2828
2016
Q2 		$110K Buy
18,131
+2,296
+14% +$18.7K ﹤0.01% 2925
2016
Q1 		$135K Sell
15,835
-422
-3% -$3.69K ﹤0.01% 2768
2015
Q4 		$194K Sell
16,257
-7,116
-30% -$89.9K ﹤0.01% 2587
2015
Q3 		$236K Buy
23,373
+328
+1% +$4.89K ﹤0.01% 2626
2015
Q2 		$382K Buy
23,045
+5,202
+29% +$82.4K ﹤0.01% 2376
2015
Q1 		$276K Buy
17,843
+3,191
+22% +$48.3K ﹤0.01% 2490
2014
Q4 		$232K Buy
14,652
+1,141
+8% +$14.9K ﹤0.01% 2538
2014
Q3 		$144K Buy
13,511
+3,660
+37% +$33.9K ﹤0.01% 2801
2014
Q2 		$93K Buy
9,851
+227
+2% +$1.45K ﹤0.01% 3086
2014
Q1 		$66K Buy
9,624
+2,114
+28% +$12.5K ﹤0.01% 3185
2013
Q4 		$29K Buy
7,510
+366
+5% +$1.48K ﹤0.01% 3327
2013
Q3 		$36K Buy
7,144
+1,457
+26% +$8.91K ﹤0.01% 3247
2013
Q2 		$36K Buy
+5,687
New +$36.4K ﹤0.01% 3215

Other funds holding TGTX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock Advisors's TGTX Position: Q4 2016 in Review

BlackRock Advisors reduced its TG Therapeutics (TGTX) stake by 3.8% in Q4 2016, selling an estimated $4.33K and leaving 18,942 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

BlackRock Advisors first reported a position in TGTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $382K in Q2 2015. 91 funds tracked by Wall St. Rank hold TGTX as of Q4 2016.

  • BlackRock Advisors held 18,942 shares of TG Therapeutics worth $88K as of Q4 2016.
  • BlackRock Advisors sold 738 TG Therapeutics shares in Q4 2016, an estimated $4.33K.
  • TG Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3086 holding.
  • BlackRock Advisors first reported a position in TG Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's TG Therapeutics position peaked at $382K in Q2 2015.
  • 91 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.